Gerald L. Ray & Associates’s Eli Lilly LLY Stock Holding History

Gerald L. Ray & Associates’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$3.16M	Hold	36,921	–	–	0.39%	65
2017 Q2	$3.04M	Hold	36,921	–	–	0.39%	65
2017 Q1	$3.1M	Hold	36,921	–	–	0.43%	63
2016 Q4	$2.72M	Buy	36,921 +250	+0.7%	+$18.6K	0.39%	66
2016 Q3	$2.94M	Sell	36,671 -1,000	-3%	-$80K	0.44%	60
2016 Q2	$2.97M	Hold	37,671	–	–	0.47%	55
2016 Q1	$2.71M	Sell	37,671 -579	-2%	-$43.8K	0.44%	57
2015 Q4	$3.22M	Buy	38,250 +50	+0.1%	+$4.15K	0.51%	51
2015 Q3	$3.2M	Sell	38,200 -650	-2%	-$54.9K	0.53%	48
2015 Q2	$3.24M	Hold	38,850	–	–	0.49%	50
2015 Q1	$2.82M	Hold	38,850	–	–	0.42%	60
2014 Q4	$2.68M	Hold	38,850	–	–	0.41%	60
2014 Q3	$2.52M	Hold	38,850	–	–	0.41%	62
2014 Q2	$2.42M	Hold	38,850	–	–	0.41%	67
2014 Q1	$2.29M	Buy	38,850 +650	+2%	+$36.3K	0.41%	67
2013 Q4	$1.95M	Hold	38,200	–	–	0.37%	71
2013 Q3	$1.92M	Hold	38,200	–	–	0.4%	65
2013 Q2	$1.88M	Buy	+38,200	New	+$2.08M	0.42%	63

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Gerald L. Ray & Associates's LLY Position: Q3 2017 in Review

Gerald L. Ray & Associates held its Eli Lilly (LLY) position steady in Q3 2017 at 36,921 shares worth $3.16M. The position accounts for 0.39% of the portfolio, ranked #65.

Gerald L. Ray & Associates first reported a position in LLY in Q2 2013 and has held it in 18 quarters since. The position peaked at $3.24M in Q2 2015. 1,228 funds tracked by Wall St. Rank hold LLY as of Q3 2017.

Gerald L. Ray & Associates held 36,921 shares of Eli Lilly worth $3.16M as of Q3 2017.
Gerald L. Ray & Associates left its Eli Lilly share count unchanged in Q3 2017.
Eli Lilly made up 0.39% of Gerald L. Ray & Associates's portfolio in Q3 2017, its #65 holding.
Gerald L. Ray & Associates first reported a position in Eli Lilly in Q2 2013 and has held it in 18 quarters since.
Gerald L. Ray & Associates's Eli Lilly position peaked at $3.24M in Q2 2015.
1,228 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2017.

Based on Gerald L. Ray & Associates's 13F filing for Q3 2017, filed 31 Oct 2017.